[5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium

C40H37N4O13+ — CID 163182951

IUPAC[5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium
SMILES[NH2+]=C1C=CC(CCOc2ccc(C3C=C(O)c4c(cc(OC5OC(C(=O)O)C6(O)C(C7=NC=NC7)C=CC5(O)C6O)c(OCc5cccc(O)c5)c4O)O3)cc2)=N1
InChIInChI=1S/C40H36N4O13/c41-31-9-6-22(44-31)11-13-53-24-7-4-21(5-8-24)28-15-27(46)32-29(55-28)16-30(34(33(32)47)54-18-20-2-1-3-23(45)14-20)56-38-39(51)12-10-25(26-17-42-19-43-26)40(52,37(39)50)35(57-38)36(48)49/h1-10,12,14-16,19,25,28,35,37-38,41,45-47,50-52H,11,13,17-18H2,(H,48,49)/p+1
InChIKeyVDRLGHNUNFJZLA-UHFFFAOYSA-O
MW781.75 g/mol
LogP1.33
Rot. Bonds12

About [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium

[5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium (PubChem CID 163182951) has the molecular formula C40H37N4O13+ and a molecular weight of 781.75 g/mol. Its IUPAC name is [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium.

Molecular Properties

Compound Name[5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium
PubChem CID163182951
Molecular FormulaC40H37N4O13+
Molecular Weight781.75 g/mol
Exact Mass781.24
IUPAC Name[5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium
SMILES[NH2+]=C1C=CC(CCOc2ccc(C3C=C(O)c4c(cc(OC5OC(C(=O)O)C6(O)C(C7=NC=NC7)C=CC5(O)C6O)c(OCc5cccc(O)c5)c4O)O3)cc2)=N1
InChIInChI=1S/C40H36N4O13/c41-31-9-6-22(44-31)11-13-53-24-7-4-21(5-8-24)28-15-27(46)32-29(55-28)16-30(34(33(32)47)54-18-20-2-1-3-23(45)14-20)56-38-39(51)12-10-25(26-17-42-19-43-26)40(52,37(39)50)35(57-38)36(48)49/h1-10,12,14-16,19,25,28,35,37-38,41,45-47,50-52H,11,13,17-18H2,(H,48,49)/p+1
InChIKeyVDRLGHNUNFJZLA-UHFFFAOYSA-O
XLogP1.33
TPSA267.50 Ų
H-Bond Donors8
H-Bond Acceptors14
Rotatable Bonds12
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500781.75
LogP ≤ 51.33
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium?
The IUPAC name of [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium (CID 163182951) is [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium.
What is the SMILES notation for [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium?
The canonical SMILES for [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium is [NH2+]=C1C=CC(CCOc2ccc(C3C=C(O)c4c(cc(OC5OC(C(=O)O)C6(O)C(C7=NC=NC7)C=CC5(O)C6O)c(OCc5cccc(O)c5)c4O)O3)cc2)=N1.
What is the InChIKey of [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium?
The InChIKey is VDRLGHNUNFJZLA-UHFFFAOYSA-O. The full InChI is InChI=1S/C40H36N4O13/c41-31-9-6-22(44-31)11-13-53-24-7-4-21(5-8-24)28-15-27(46)32-29(55-28)16-30(34(33(32)47)54-18-20-2-1-3-23(45)14-20)56-38-39(51)12-10-25(26-17-42-19-43-26)40(52,37(39)50)35(57-38)36(48)49/h1-10,12,14-16,19,25,28,35,37-38,41,45-47,50-52H,11,13,17-18H2,(H,48,49)/p+1.
What are the key properties of [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium?
[5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium has a molecular weight of 781.75 g/mol, XLogP of 1.33, 12 rotatable bonds, 8 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [5-[2-[4-[7-[[4-carboxy-1,5,9-trihydroxy-6-(4H-imidazol-5-yl)-3-oxabicyclo[3.3.1]non-7-en-2-yl]oxy]-4,5-dihydroxy-6-[(3-hydroxyphenyl)methoxy]-2H-chromen-2-yl]phenoxy]ethyl]pyrrol-2-ylidene]azanium is sourced from PubChem (CID 163182951), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).